Market Place
Sourcing Support
Roche culls ph. 3 Spark gene therapy in hemophilia
18 Dec 2024 //
FIERCE BIOTECH
Roche Axes Gene Therapy For Pompe Disease Due To Competition
25 Jul 2024 //
FIERCE BIOTECH
Spark co-founder launches new CNS gene therapy biotech with $54M
02 May 2024 //
ENDPTS
Spark lines up next retinal gene therapy pact in Barcelona
17 Oct 2023 //
ENDPTS
Roche writes off $3B on lower sales forecasts for gene therapies, cancer drugs
03 Feb 2023 //
BIOPHARMADIVE
Spark Therapeutics Enters Into Strategic Collaboration with Neurochase
27 Jan 2023 //
GLOBENEWSWIRE
Roche’s hemophilia gene therapy holds steady with longer-term data
13 Dec 2022 //
BIOPHARMADIVE
Chroma Welcomes Spark Co-Founder Jeff Marrazzo to Board of Directors
04 Oct 2022 //
PRNEWSWIRE
Roche, bluebird settle gene therapy trademark suit
19 May 2022 //
FIERCEPHARMA
Roche`s gene therapy unit gets new Spark as CEO departs April 1
23 Feb 2022 //
FIERCEBIOTECH
Roche loses one bid against bluebird`s `spark` DTC ad
27 Jan 2022 //
FIERCEPHARMA
Astellas inks $1.6B pact with Dyno to continue gene therapy play
01 Dec 2021 //
FIERCEBIOTECH
Roche`s Spark adds epilepsy asset to pipeline with $328M deal
13 Oct 2021 //
FIERCEBIOTECH
Spark Therapeutics and CombiGene Enter into Exclusive, Global Licensing Agreemen
12 Oct 2021 //
GLOBENEWSWIRE
Spark Founders Launch Opus Genetics to Tackle Rare Forms of Blindness
22 Sep 2021 //
BIOSPACE
Limbix Expands Leadership Team to Aid Development of SparkRx Digital Therapeutic
22 Sep 2021 //
BUSINESSWIRE
Quidel recalls COVID-19 PCR tests over risk of false negatives
11 Jul 2021 //
FIERCEBIOTECH
Revolutionary Treatment for Hemophilia B Shows Promise in Clinical Trials
17 May 2021 //
BUSINESSWIRE
Tim Lu’s gene-circuit star Senti signs up for a $645M alliance with Roche
14 Apr 2021 //
ENDPTS
Spark Announces Preliminary Data from Phase 1/2 Clinical Trial of SPK-8016
05 Feb 2021 //
GLOBESNEWSWIRE
Spark co-founder Dr. Katherine High takes C-suite role at NC
13 Jan 2021 //
BIZJOURNALS
Spark co-founder Kathy High joins a longtime collaborator at AskBio
13 Jan 2021 //
ENDPTS
SparingVision raises $52M to kick off long journey for a next-gen gene therapy
20 Oct 2020 //
ENDPTS
Spark Therapeutics nabs CMO from new owner Roche
12 Aug 2020 //
FIERCE BIOTECH
Spark Therapeutics nabs CMO from new owner Roche
11 Aug 2020 //
FIERCE BIOTECH
Spark Therapeutics Announces Updated Data on SPK-8011
13 Jul 2020 //
GLOBENEWSWIRE
Spark, chasing BioMarin, plans 2021 start for key hemophilia gene therapy study
13 Jul 2020 //
BIOPHARMADIVE
Better than Eylea, as durable as gene therapy? Perceptive, Xontogeny boost
24 Jun 2020 //
ENDPTS
Gene therapy shows promise in retinitis pigmentosa model
11 Jun 2020 //
FIERCE BIOTECH
Study Demonstrating Role of IdeS in Enabling of Gene Therapy of Neutralizing
01 Jun 2020 //
GLOBENEWSWIRE
Texas university spins out Taysha, a gene therapy startup with 15 programs
29 Apr 2020 //
BIOPHARMADIVE
Spark, Ipsen and more join Rare Disease Day 2020 efforts
29 Feb 2020 //
FIERCE PHARMA
Spark`s CMO set to leave as post-Roche takeover exits continue
28 Feb 2020 //
FIERCE BIOTECH
Gene therapy pioneer Kathy High has left Spark after $4.3B union with Roche
22 Feb 2020 //
ENDPTS
Spark R&D chief High exits in wake of Roche takeover
22 Feb 2020 //
FIERCE BIOTECH
Watch out, Roche. BioMarin`s gene therapy might bleed off
14 Jan 2020 //
FIERCE PHARMA
Large study of heart stenting vs surgery sparks controversy
02 Jan 2020 //
REUTERS
Roche to pay Sarepta $1B upfront for DMD gene therapy rights
24 Dec 2019 //
FIERCE BIOTECH
After FTC surprises, pharma should expect more M&A scrutiny in 2020
21 Dec 2019 //
FIERCE PHARMA
What FTC scrutiny should biopharma M&As expect in 2020?
19 Dec 2019 //
FIERCE PHARMA
Manufacturing: the next breakthrough in gene therapy
19 Dec 2019 //
STATNEWS
Roche wraps up $4.3B Spark buyout as FTC thumbs-up ends antitrust ordeal
18 Dec 2019 //
FIERCEPHARMA
Roche`s $4.8B deal for Spark cleared by FTC after long delay
17 Dec 2019 //
BIOPHARMADIVE
Roche-Spark`s U.K. antitrust nod tees up similar FTC ruling
16 Dec 2019 //
FIERCE PHARMA
Blueprint’s Phase II avapritinib sparks concerns on risk-benefit profile
11 Dec 2019 //
CLINICALTRIALSARENA
Swiss drugmaker Roche again extends $4.3 bln Spark offer until Dec. 16
11 Dec 2019 //
REUTERS
Biotech is beating health care by double this year—here’s how one investor
10 Dec 2019 //
CNBC
Roche extends tender offer for shares of Spark Therapeutics to December 16, 2019
10 Dec 2019 //
PHARMABIZ
Is Roche finally near a Spark deal antitrust decision?
09 Dec 2019 //
FIERCE PHARMA
Antitrust reviews delay Roche`s Spark deal further
23 Nov 2019 //
FIERCE PHARMA
Another extension for Roche-Spark takeover offer
22 Nov 2019 //
CONTRACT PHARMA
Pfizer `brainstorming` with payers on gene therapy payment
09 Nov 2019 //
FIERCE PHARMA
Roche — surprise — delays $4.3B Spark buyout again as regulators hover
30 Oct 2019 //
ENDPTS
Roche-Spark sees hope as FTC staff gives thumbs-up: report
26 Oct 2019 //
FIERCE PHARMA
Where is that Sandoz U.S. generics deal with Aurobindo?
24 Oct 2019 //
FIERCE PHARMA
Roche sets new deadline for Spark acquisition as divestiture speculation brews
30 Sep 2019 //
ENDPTS
Another big biopharma merger runs into another snag at the FTC. What now?
28 Sep 2019 //
ENDPTS
Is the FTC about to force Roche to divest a key hemophilia program
26 Sep 2019 //
ENDPTS
Roche-Spark UK deal review unnerves already-spooked M&A watchers
26 Sep 2019 //
FIERCE PHARMA
Roche and Spark Continue to See Delays for Pending Deal
07 Sep 2019 //
BIOSPACE
